Your browser doesn't support javascript.
loading
Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer - results from a real-world setting.
KovaC, Anja; Matos, Erika; Kuhar, Cvetka Grasic; Caks, Marina; Ovcaricek, Tanja; Mencinger, Marina; Humar, Mojca; Borstnar, Simona.
Afiliação
  • KovaC A; Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia; Izola General Hospital, Polje 40, 6310 Izola, Slovenia. Electronic address: ankovac@onko-i.si.
  • Matos E; Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
  • Kuhar CG; Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
  • Caks M; University Clinical Center Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia.
  • Ovcaricek T; Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
  • Mencinger M; Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
  • Humar M; General Hospital "dr. Franc Derganc" Nova Gorica, Ulica padlih borcev 13A, 5290 Sempeter pri Gorici, Slovenia.
  • Borstnar S; Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia. Electronic address: sborstnar@onko-i.si.
Cancer Treat Res Commun ; 25: 100201, 2020.
Article em En | MEDLINE | ID: mdl-32979704
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2020 Tipo de documento: Article